寻找海洛因的灭绝不需要内皮层或其投射到核的或杏仁核
Matthew S McGregor1, Kelle E Nett1, Subhash C Gupta2,3
1Interdisciplinary Graduate Program in Neuroscience, University of Iowa, Iowa City, Iowa, USA.
Addiction biology
|October 21, 2025
概括
阴下皮层 (IL) 途径对于可卡因灭绝至关重要,但对于大鼠的海洛因灭绝学习至关重要. 这项研究揭示了不同成药物寻求行为的灭绝背后的独特神经机制.
科学领域:
- 神经科学是一个神经科学.
- 行为神经科学 行为神经科学
- 成研究 研究成研究
背景情况:
- 阴下皮层 (IL) 和其投射到核 (NAshell) 和杏仁体对于可卡因灭绝学习至关重要.
- 尚不清楚类似的神经回路是否会调解阿片类药物等其他成性物质的灭绝.
- 了解这些途径对于开发有针对性的成治疗至关重要.
研究的目的:
- 调查IL及其预测在海洛因寻求行为的灭绝中的作用.
- 将海洛因灭绝的神经机制与可卡因灭绝的神经机制进行比较.
- 探索海洛因自我管理和灭绝学习中的潜在性别差异.
主要方法:
- 在雌性和雄性Sprague-Dawley大鼠中采用了一种行为控制的光遗传方法.
- 老鼠接受了海洛因自我管理,随后接受了灭绝训练.
- 在早期灭绝期间,在未加强的杆压力后立即应用IL,IL-NAshell或IL-杏仁体通路的光遗传抑制.
主要成果:
- 对IL或其投射的光遗传抑制没有影响在海洛因灭绝训练或保留期间的杆按压.
- 这些发现与相同途径在可卡因灭绝中的已知关键作用形成鲜明对比.
- 在灭绝学习中没有观察到任何显著的性别差异,但女性在较短的会议中显示出更高的海洛因摄入量.
结论:
- 涉及到下边缘皮层的神经回路对于海洛因寻求行为的灭绝并不至关重要.
- 不同的神经机制是不同成药物的寻求行为灭绝的基础.
- 会议长度影响了海洛因自我管理中的性别差异.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
908
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K


